| abstract |
Reagents that regulate human hematopoietin receptor-like protein and reagents which bind to human hematopoietin receptor-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, CNS disorders, COPD, cardiovascular disorders, liver disorders, cancer, asthma, and hematological disorders. |